Home › Atherosclerosis › Illinois › Springfield
Atherosclerosis clinical trials in Springfield, IL
3 studies for Atherosclerosis are looking for participants at sites in and around Springfield (within about 30 miles). Open a study to see who can join and how to contact the study team.
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
RecruitingPhase 3
- Central Illinois Diabetes and Clinical Research a Division of Prairie Education and Research Cooperative, Springfield
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
RecruitingPhase 2
- Southern Illinois University School of Medicine, Springfield
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RecruitingPhase 3
- Prarie Education and Research, Springfield
About Atherosclerosis
Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.
More about Atherosclerosis on MedlinePlus
Atherosclerosis trials in other cities
- Boston, MA10 studies
- Houston, TX10 studies
- Washington, DC9 studies
- Hialeah, FL8 studies
- Arlington, VA8 studies
- Orlando, FL8 studies
- Dallas, TX7 studies
- Durham, NC7 studies
- Memphis, TN7 studies
- Las Vegas, NV7 studies
- Miami, FL7 studies
- The Woodlands, TX6 studies
Other studies in Springfield
- Non-Small Cell Lung Cancer13 studies
- Lung Cancer12 studies
- Colorectal Cancer9 studies
- Breast Cancer8 studies
- Acute Myeloid Leukemia8 studies
- Cancer (all types)7 studies
- Kidney Cancer (Renal Cell Carcinoma)6 studies
- Bladder Cancer6 studies
- Prostate Cancer6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Melanoma5 studies
- Pancreatic Cancer5 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.